Latest news with #Demant
Business Insider
a day ago
- Business
- Business Insider
Positive Report for Demant (WILLF) from Morgan Stanley
Morgan Stanley analyst Terence Tsui upgraded Demant (WILLF – Research Report) to a Buy yesterday and set a price target of DKK335.00. The company's shares closed last Thursday at $38.23. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Tsui is a 3-star analyst with an average return of 3.5% and a 57.58% success rate. Tsui covers the Communication Services sector, focusing on stocks such as BT Group plc, Tele2 AB, and Telenor. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Demant with a $43.78 average price target, representing a 14.52% upside. In a report released today, Kepler Capital also upgraded the stock to a Buy with a DKK315.00 price target. Based on Demant's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $11.33 billion and a net profit of $1.18 billion. In comparison, last year the company earned a revenue of $11.35 billion and had a net profit of $1.21 billion
Japan Times
15-05-2025
- Business
- Japan Times
Trump's tariffs spare Europe-dominated hearing aid industry
Just northwest of Copenhagen, a cluster of small towns surrounded by trees and lakes is home to three of the world's biggest hearing-aid manufacturers. The area's outsized control of the market, which has helped Denmark earn the moniker "Silicon Valley of Sound,' seems set to endure after devices for chronic disabilities were among the rare segments to escape the burn of tariffs imposed by U.S. President Donald Trump. An ecosystem developed over more than a century has given the three Danish companies Demant, GN Store Nord and WS Audiology — together with their Swiss rival Sonova Holding — a quasi-monopoly on the market for devices that help people hear better. This small yet sensitive medical-care segment was shielded from tariffs during Trump's first term and spared again from the barrage of levies he unleashed last month. "At this point in time, we are exempt from tariffs and we do assume in our planning that we will continue to be that,' Peter Karlstromer, CEO of GN Store Nord, said on an earnings call on May 1.
